Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-12-08
1989-11-28
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514274, 514554, 514555, 536 27, 544314, 562567, C07C10130, A61K 3119
Patent
active
048837865
ABSTRACT:
Novel derivatives of L-carnitine or of L-acylcarnitines or of esters thereof, obtained by salification with suitable acids or acidic aminoacids, monosalified with potassium ion.
These derivatives show cardiotropic properties in the therapy of myocardial anoxia, of ischemia, of arrythmic syndromes, of cardiac failures in general and in cases of increased energy request due to fatigue at cardiac and muscular level.
REFERENCES:
patent: 3088871 (1963-05-01), Pfeiffer
patent: 3903147 (1975-09-01), Kyncl
patent: 4075352 (1978-02-01), De Felice
patent: 4161523 (1979-07-01), Weinstein
patent: 4401827 (1983-08-01), Witt
patent: 4567200 (1986-01-01), Tinti
patent: 4649159 (1987-03-01), Fancelli
Goodman, "The Pharmacological Basis of Therapeutics", pp. 795-806 (1955).
Wilson, "Textbook of Organic Medical and Pharmaceutical Chemistry", p. 39 (1954).
"The Merck Index", 9th Ed., pp. 21, 892 & 893 (1976).
Hosein, Chem. Abstr., 67: 31250 (1967).
Magis Farmaceutici Srl
Shippen Michael L.
LandOfFree
Derivatives of L-carnitine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of L-carnitine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of L-carnitine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581869